High CK‑MB indicates damage to heart muscle — it’s a cardiac enzyme that rises after myocardial injury. Elevated levels suggest acute coronary syndrome or myocarditis, but can also occur with trauma, cardiac procedures, or skeletal muscle disease. Interpretation depends on timing, symptoms and other tests (troponin, ECG). Elevated CK‑MB warrants urgent clinical assessment to confirm cause and guide treatment.

CPK (creatine phosphokinase) is the total enzyme present in skeletal muscle, heart and brain; its level rises with general muscle injury, exercise or myopathy. CK‑MB is a cardiac‑preferential isoenzyme of CK; it is more specific for myocardial injury and is used to help diagnose and time heart attacks because it rises and falls earlier and more specifically than total CPK.

The CPK‑MB (CK‑MB) test measures the MB isoenzyme of creatine kinase to detect heart muscle injury, especially acute myocardial infarction. It rises a few hours after chest pain, peaks within 12–24 hours and normalizes within 48–72 hours. Because it’s more cardiac‑specific than total CK, it helps confirm heart attack and can detect reinfarction, often used alongside troponin tests.

Normal CK‑MB (mass) is typically about 0–5 ng/mL (many labs use <5 ng/mL as the upper limit). Some labs report slightly different cutoffs or use CK‑MB as a percentage of total CK; values above the laboratory reference range suggest myocardial injury. Always interpret results with clinical context and the specific lab’s reference range.

No — CK‑MB is not a tumor marker. It’s a creatine kinase isoenzyme measured mainly to detect cardiac muscle injury, especially in suspected myocardial infarction. Tumor markers are different substances (e.g., AFP, CEA, CA‑125, PSA) used to help diagnose or monitor cancers. CK‑MB elevations indicate muscle damage rather than malignancy.

Treatment targets the underlying cause. If elevated CK‑MB indicates acute myocardial infarction, immediate care includes aspirin and other antiplatelet agents, oxygen if hypoxic, nitroglycerin, beta‑blockers, high‑intensity statin, anticoagulation and urgent reperfusion (PCI or thrombolysis) plus ICU monitoring. For myocarditis, trauma or other causes, treat the primary condition, give supportive care, manage heart failure if present, and repeat testing/ECG follow‑up.